News 14.02.2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
Aktuell 10.05.2024 BioVersys erweitert Serie-C-Runde auf 44,9 Millionen Franken BioVersys verstärkt die Zusammenarbeit mit GSK, um die Entwicklung von Alpibectir zur Behandlung von Tuberkulose zu beschleunigen. GSK beteiligt ...
News 09.04.2024 DESI project unveils groundbreaking 3D universe map with EPFL’s aid EPFL astrophysicists have contributed to creating the most detailed 3D map of the universe, tracing expansion over 11 billion years.
News 17.04.2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 05.04.2024 Drones navigate even dense forest Researchers at the Swiss Federal Institute for Forest, Snow and Landscape Research (WSL) and the Swiss Federal Institute of Technology Zurich hav...
News 04.04.2024 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...
News 13.03.2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
News 07.03.2024 Jedsy cooperates with the TCS to insure drone deliveries Drone specialist Jedsy from the canton of St.Gallen has entered into a partnership with the Touring Club Switzerland (TCS) to insure drone delive...
Aktuell 04.04.2024 Galderma realisiert weltweit grössten Börsengang Die Kotierung an der Schweizer Börse hat Galderma knapp 2,3 Milliarden Franken eingebracht. Damit stellt das Pharmaunternehmen im ersten Quartal ...
Aktuell 26.03.2024 Zürcher Forschende machen Krebstherapie wieder wirksam Forschende der Universität Zürich und des Universitätsspitals Zürich haben herausgefunden, wie mutierte Blutkrebszellen wieder auf eine Immunther...
Actualités 17.04.2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Actualités 09.04.2024 Le projet DESI dévoile une carte 3D inédite de l’univers avec l’aide de l’EPFL Des astrophysiciens de l’EPFL ont contribué à la création de la carte 3D la plus détaillée de l’univers, retraçant son expansion sur 11 milliards...
News 19.12.2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News 27.01.2021 Institute develops double antibody against COVID-19 Researchers at the Institute for Research in Biomedicine have managed to combine two antibodies against COVID-19 into a single entity. This doubl...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Fiches d’information 03.04.2024 Le secteur de l'énergie au Guatemala Le secteur de l’énergie est modeste au Guatemala mais subit les effets de la transition énergétique. Le secteur a besoin de technologies pour rép...
News 15.12.2023 OST showcases robots to assist older people The Institute for Ageing Research (IAF) at OST - Eastern Switzerland University of Applied Sciences has launched a website that showcases the app...